FLOT
Showing 1 - 25 of 77
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022
Gastric Cancer Trial in Krakow (FLOT4 + HIPEC + Surgery, FLOT4 + Surgery)
Recruiting
- Gastric Cancer
- FLOT + HIPEC + Surgery
- FLOT + Surgery
-
Krakow, Lesser Poland Voivodship, PolandDepartment of General, Oncological, Gastroenterological Surgery
Nov 9, 2022
Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2023
Esophageal Squamous Cell Carcinoma Trial in Tokyo (FLOT therapy)
Recruiting
- Esophageal Squamous Cell Carcinoma
- FLOT therapy
-
Tokyo, JapanKeio University Hospital
Aug 15, 2022
Esophagogastric Adenocarcinoma Trial (Pembrolizumab, Trastuzumab, FLOT)
Not yet recruiting
- Esophagogastric Adenocarcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Aug 17, 2022
Locally Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Albumin Taxol, FLOT scheme)
Not yet recruiting
- Locally Advanced Gastric Cancer
- Camrelizumab
- +2 more
-
Fuzhou, Fujian, China
- +1 more
Nov 8, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)
Active, not recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Atezolizumab
- +4 more
-
Frankfurt, Germany
- +1 more
Apr 14, 2022
ive Exposure to 5-FU in Locally Advanced, Resectable Gastric or
Recruiting
- TDM of 5-FU
- Pharmacokinetic Observational Study
- Extra blood samples for determining exposure to 5-FU
-
Eindhoven, Noord-Brabant, NetherlandsCatharina hospital
Dec 28, 2022
PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer Trial in Changchun (Drug: Toripalimab,
Recruiting
- PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer
- Drug: Toripalimab, FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU)
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Jul 18, 2022
Cancer of Stomach, Adenocarcinoma Trial in Hong Kong (5-FU, Leucovorin, Oxaliplatin, Docetaxel, XELOX)
Recruiting
- Cancer of Stomach, Adenocarcinoma
- 5-FU, Leucovorin, Oxaliplatin, Docetaxel
- XELOX
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Mar 21, 2022
Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)
Active, not recruiting
- Adenocarcinoma of the Stomach
- GastroEsophageal Cancer
- Nivolumab
- +3 more
-
Amberg, Germany
- +26 more
Jan 12, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- 5-Fluorouracil
- +4 more
-
Aachen, Germany
- +14 more
Sep 7, 2022
Adenocarcinoma Esophagus, Adenocarcinoma of the Gastroesophageal Junction Trial in Colorado Springs, Lone Tree (Sequential FLOT
Recruiting
- Adenocarcinoma Esophagus
- Adenocarcinoma of the Gastroesophageal Junction
- Sequential FLOT followed by chemoradiation
-
Colorado Springs, Colorado
- +2 more
Feb 22, 2022
Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)
Not yet recruiting
- Esophagus Adenocarcinoma
- Durvalumab
- +3 more
-
Frankfurt, GermanyInstitute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Feb 7, 2023
Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)
Recruiting
- Gastric Cancer
- Taurine
- +3 more
-
Xi'an, Shaanxi, ChinaTang-Du Hospital
Nov 7, 2023
Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)
Active, not recruiting
- Gastric Cancer
- Docetaxel
- +4 more
-
Mykolaiv, UkraineUkrainian Society of Clinical Oncology
Apr 11, 2022
Gastric Cancer, Neoadjuvant Chemo Trial in Shanghai (Chemotherapy)
Not yet recruiting
- Gastric Cancer
- Neoadjuvant Chemotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiaotong University School of Medicine
Jul 15, 2021
Gastric and Esophagogastric Junction Adenocarcinoma Trial in Zhengzhou (PD-1 Monoclonal Antibody(Sintilimab))
Recruiting
- Gastric and Esophagogastric Junction Adenocarcinoma
- PD-1 Monoclonal Antibody(Sintilimab)
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 23, 2021
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Gastric Cancer by AJCC V8 Stage, Resectable Carcinoma Trial in Caen (perioperative treatment)
Recruiting
- Gastric Cancer by AJCC V8 Stage
- Resectable Carcinoma
- perioperative treatment
-
Caen, FranceCentre François Baclesse
Jun 28, 2021
Chemo, Gastric Cancer Trial in Guangzhou (FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1))
Recruiting
- Chemotherapy
- Gastric Cancer
- FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1)
-
Guangzhou, Guangdong, ChinaGuangdong Province Hospital of Chinese Medicine, the Second Affi
May 10, 2021
Stomach Tumors, Gastrointestinal Tumors, Docetaxel Trial in Moscow (Irinotecan, 5-FU, Leucovorin)
Recruiting
- Stomach Neoplasms
- +5 more
- Irinotecan
- +4 more
-
Moscow, Russian FederationAleksei Kalinin
Apr 12, 2021
Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer China
Completed
- Chemotherapy Effect
-
Shanghai, Shanhgai, ChinaRuijin Hospital Shanghai Jiaotong University School of Medicine
Nov 10, 2020
Gastric Cancer Trial in Tianjin (Toripalimab, Docetaxel, Fluorouracil)
Recruiting
- Gastric Cancer
- Toripalimab
- +4 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 16, 2021